FKnol.com

Financial Knowledge & Information Portal

Bristol-Myers Squibb (BMY) Company Profile

Updated Jun 19, 2020
Bristol-Myers Squibb has the following business profile:
Company's Full Name:Bristol-Myers Squibb Company
Short Name:Bristol-Myers Squibb
Trading Ticker Symbol:BMY
Primary Exchange:NYSE
Headquarter City/Country:New York, NY
Primary Industry Sector:Health Care
Seconday Sub-sector:Major Pharmaceuticals
Main Business Areas: Health Care, Major Pharmaceuticals, Major Drug Manufacturers, Pharma, Healthcare, S&P 500
Dividend Payments:Dividend History
Technical Analysis:Recent Candlestick Patterns
ETFs Holding:List of ETFs holding Bristol-Myers Squibb stock

Market and Trading Information for Bristol-Myers Squibb

The following details were available for trading and market data about the stock of Bristol-Myers Squibb as of writing:
Current Share Price:$56.41
Previous Year's Closing Price:$64.19
Percentage Price Change (YTD):-12.12%
Market Cap:$127.64 billion
52-week Price Range:$42.48 - $68.34
Dividend Per Share:$1.72
EPS (TTM):0.51
Price-Earnings (Trailing):109.96
Price-Earnings (Forward):7.61

Company Profile and Business Description for Bristol-Myers Squibb

Bristol-Myers Squibb Company, incorporated on August 11, 1933, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

Empliciti

The Company's Empliciti, a biological product, is a humanized monoclonal antibody for the treatment of multiple myeloma. Empliciti is approved for the treatment of multiple myeloma as combination therapy with Revlimid and dexamethasone in patients having received one prior therapy.

Opdivo

The Company's Opdivo, a biological product, is a human monoclonal antibody that binds to the programmed death receptor-1 (PD-1) on T and natural killer T (NKT) cells. Opdivo has received approvals for various indications, including melanoma, head and neck, lung, kidney and blood cancer. The Opdivo+Yervoy regimen also is approved in multiple markets for the treatment of melanoma. There are various registrational trials for Opdivo across other tumor types and other disease areas.

Sprycel

The Company's Sprycel is a multi-targeted tyrosine kinase inhibitor approved for the first-line treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. Sprycel is also approved for the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy, including Gleevec (imatinib mesylate).

Yervoy

The Company's Yervoy, a biological product, is a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The Company is evaluating Yervoy in a Phase III trial in stage III melanoma patients at risk of recurrence following complete surgical resection.

Eliquis

The Company's Eliquis is an oral Factor Xa inhibitor targeted at stroke prevention in atrial fibrillation. Eliquis is also targeted for the prevention and treatment of venous thromboembolic (VTE) disorders.

Orencia

The Company's Orencia, a biological product, is a fusion protein with immunosuppressive activity targeted initially at adult patients with moderately to various active rheumatoid arthritis (RA). Orencia ClickJect Autoinjector is a self-administered autoinjector for adults with moderate to severe RA.

Baraclude

The Company's Baraclude is a selective inhibitor of hepatitis B virus. Baraclude is sold in the United States and International.

Hepatitis C Franchise

The Company's Daklinza (daclatasvir (DCV)) is an oral small molecule nonstructural protein 5A (NS5A) replication complex inhibitor for the treatment of hepatitis C virus infection (HCV) and is approved for use with Gilead Sciences, Inc.'s (Gilead) sofosbuvir. Its Sunvepra (asunaprevir (ASV)) is an oral small molecule nonstructural 3 protein (NS3) protease inhibitor for the treatment of HCV and is part of the dual regimen of DCV+ASV in Japan. Its Beclabuvir (BCV) is an oral small molecule non-nucleoside nonstructural protein 5B (NS5B) inhibitor for the treatment of HCV and is part of the triple combination tablet, Ximency, (DCV+ASV+BCV) in Japan.

Reyataz Franchise

The Company's Reyataz is a protease inhibitor for the treatment of HIV. The Reyataz Franchise includes Reyataz and combination therapy Evotaz (atazanavir 300 milligram (mg) and cobicistat 150 mg), a once-daily single tablet two drug regimen combining Reyataz and Gilead's Tybost (cobicistat) for the treatment of HIV-1 infection in adults.

Sustiva Franchise

The Company's Sustiva is a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV. The Sustiva Franchise includes Sustiva, an antiretroviral drug used in the treatment of HIV, as well as bulk efavirenz, which is included in the combination therapy Atripla (efavirenz 600 mg, emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg), a once-daily single tablet three-drug regimen combining its Sustiva and Gilead's Truvada (emtricitabine and tenofovir disoproxil fumarate).

345 PARK AVE

ETFs Holding Bristol-Myers Squibb Stock

As of March 2020, the following exchange-traded funds (ETF) hold the Bristol-Myers Squibb stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Bristol-Myers Squibb stock holding. There are a total of 204 ETFs in Fknol.com records which are holding Bristol-Myers Squibb stock in their portfolio. See Full List.

TickerNameShort DescriptionExpense
Ratio
No. of
Holdings
Dividend
Frequency
FLAGFLAG-Forensic Accounting Long-Short ETFThe FLAG-Forensic Accounting Long-Short ETF tracks an index that selects long and short equity positions of large-cap U.S. companies relative to their earnings quality and revenue recognition practices. ...Full Details1.61%137
Full List
Quarterly
ACIMSPDR MSCI ACWI IMI ETFThe SPDR MSCI ACWI IMI ETF tracks a market-cap-weighted index of global stocks covering 98% of the capitalization of the developed and emerging markets. ...Full Details0.25%906
Full List
Semi-Annually
ACWIiShares MSCI ACWI ETFThe iShares MSCI ACWI ETF tracks a market-cap-weighted index of large- and midcap global stocks, covering 85% of the developed and emerging markets capitalization. ...Full Details ...Candlestick Patterns.0.32%1596
Full List
Semi-Annually
ACWViShares Edge MSCI Min Vol Global ETFThe iShares Edge MSCI Min Vol Global ETF tracks an index of large- and midcap global stocks selected and weighted to create a low volatility portfolio subject to constraints including sector exposure. ...Full Details0.2%426
Full List
Semi-Annually
BVALBrand Value ETFThe Brand Value ETF tracks an equal-weighted index of 50 US companies determined to have the most undervalued brands relative to their market capitalization. ...Full Details0.65%51
Full List
Annually
CHGXChange Finance Diversified Impact US Large Cap Fossil Fuel Free ETFCHGX tracks an index of 100 US large-cap stocks that meet diverse environmental, social, and governance standards. ...Full Details0.49%101
Full List
Annually
CRBNiShares MSCI ACWI Low Carbon Target ETFThe iShares MSCI ACWI Low Carbon Target ETF tracks an index of stocks from global firms selected for a bias toward lower carbon emissions, but with tight constraints to the broad, marketlike ACWI index. ...Full Details0.2%1204
Full List
Semi-Annually
CSMProshares Large Cap Core PlusThe ProShares Large Cap Core Plus ETF tracks a long/short index of the 500 largest US stocks. It uses a set of rules to assign weights to each equity that add up to 130% long and 30% short exposure. ...Full Details0.45%320
Full List
Quarterly
DEWWisdomTree Global Equity Income FundThe WisdomTree Global High Dividend ETF tracks an index of the top 30% of global dividend-paying stocks ranked by dividend yield and weighted by dividends. ...Full Details0.58%660
Full List
Quarterly
DGROiShares Core Dividend Growth ETFThe iShares Core Dividend Growth ETF tracks an index of US stocks that are selected by dividends, dividend growth and payout ratio, then weighted by dividend dollars. ...Full Details0.08%449
Full List
Quarterly

See Full List of ETFs holding Bristol-Myers Squibb stock in their respective portfolios.

Peer / Competitor Companies of Major Pharmaceuticals Sector

Along with Bristol-Myers Squibb Company, the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Health Care sector whose company profile and dividend history is as follows:

▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile,  Dividend History

▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile,  Dividend History

▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile,  Dividend History

▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile,  Dividend History

▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile,  Dividend History

▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile,  Dividend History

▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile,  Dividend History

▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile,  Dividend History

▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile,  Dividend History

▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile,  Dividend History

▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile,  Dividend History

▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile,  Dividend History

▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile,  Dividend History

▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile,  Dividend History

▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile,  Dividend History

▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile,  Dividend History

▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile,  Dividend History

▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile,  Dividend History

... See Full List of All Stocks of Major Pharmaceuticals Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Biotechnology Sector

▶ Stocks of Diagnostics & Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Drug Manufacturers—Specialty & Generic Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Care Facilities Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Devices Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Instruments & Supplies Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Discretionary Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Healthcare Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector